Inflamazyme offers a wonderful high dose potency of nattokinase, serrapeptase, bromelain and other proteolytic enzymes that can be beneficial in the reduction of fibrous structures in Dupuytren’s contracture.
– Formula comprised of key therapeutic enzymes
– Ingredients support anti-inflammatory and fibrinolytic (anti-encapsulation) activity
– Additionally supports circulatory and immune function.
NATTOKINASE is created by the bacterial fermentation of soybeans by the bacterium Bacillus natto. Dr. Hiroyuki Sumi discovered and described this enzyme as “the enzyme of enzymes.” Nattokinase functions as a fibrinolytic. Daily use may help reduce the risk of thrombotic events that could otherwise threaten patients’ lives. Nattokinase promotes normal circulation and oxygen perfusion to tissues.
SERRAPEPTASE is a proteolytic enzyme shown to have anti-inflammatory, anti-edemic and fibrinolytic activity. Serrapeptase provides benefits for pain reduction, reduction of viscosity of mucous, and breakdown of abnormal tissue such as scar tissue.
BROMELAIN was introduced as a medicinal agent in 1957, and since that time over 400 scientific papers studying its therapeutic applications have been published. Bromelain has been reported to exert a wide variety of beneficial effects, including helping reduce inflammation in cases of joint disease, assist recovery from injury and trauma, and help reduce swelling after surgery.
PAPAIN, TRYPSIN AND CHYMOTRYPSIN are proteolytic enzymes. Administration of proteolytic enzymes may speed the healing of injuries. Proteolytic enzymes have allowed athletes to return to performance sooner than control groups. Chymotrypsin and trypsin have been shown to reduce edema and inflammation.
Superoxide dismutase (SOD) catalyzes the destruction of the O2- free radical (superoxide). As such, it is a vitally important antioxidant and repairs cells and reduces the damage done to them by superoxide, the most common free radical in the body. Studies have shown that SOD acts as both an antioxidant and anti-inflammatory agent in the body.
MAKTREK GASTRIC BYPASS TECHNOLOGY is a state-of-the-art system that utilizes an innovative polysaccharide complex derived from seaweed. Enzymes are protein molecules and exposure to the acidic environment of the stomach threatens to denature their polypeptide bonds.